Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Review

Adverse drug event reporting systems: a systematic review.

Bailey C, Peddie D, Wickham ME, et al. Adverse drug event reporting systems: a systematic review. Br J Clin Pharm. 2016;82(1):17-29. doi:10.1111/bcp.12944.

Save
Print
September 14, 2016
Bailey C, Peddie D, Wickham ME, et al. Br J Clin Pharm. 2016;82(1):17-29.
View more articles from the same authors.

Adverse drug events (ADEs) remain one of the most common types of inpatient errors, affecting almost 5% of hospitalized patients, and lead to hundreds of thousands of emergency department visits and hospitalizations every year. Reporting ADEs is a crucial aspect of drug safety monitoring programs and international reporting standards are lacking. This study analyzed 108 ADE reporting systems and found significant variability in the data fields used to collect information. The authors suggest that standardization of data collection might improve drug safety monitoring by facilitating data aggregation on a larger scale.

Save
Print
Cite
Citation

Bailey C, Peddie D, Wickham ME, et al. Adverse drug event reporting systems: a systematic review. Br J Clin Pharm. 2016;82(1):17-29. doi:10.1111/bcp.12944.

Related Resources From the Same Author(s)
Related Resources